Yuto Fujiki

Genetic polymorphisms of CYP2B6 affect the pharmacokinetics/pharmacodynamics of cyclophosphamide in Japanese cancer patients

Miki Nakajima, Sayaka Komagata, Yuto Fujiki et al. · Pharmacogenetics and Genomics · 2007 · 128 citations

Medicine, Pharmacokinetics, Pharmacology +17

Pharmacokinetics of Paclitaxel in Ovarian Cancer Patients and Genetic Polymorphisms of CYP2C8, CYP3A4, and MDR1

Miki Nakajima, Yuto Fujiki, Satoru Kyo et al. · The Journal of Clinical Pharmacology · 2005 · 77 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

GENETIC POLYMORPHISMS OF CYP2C8 IN JAPANESE POPULATION

Miki Nakajima, Yuto Fujiki, Kumiko Noda et al. · Drug Metabolism and Disposition · 2003 · 77 citations

Medicine, Genetics, Molecular Genetics +13

Role of the aryl hydrocarbon receptor and Cyp1b1 in the antiestrogenic activity of 2,3,7,8-tetrachlorodibenzo- p -dioxin

Kei Takemoto, Miki Nakajima, Yuto Fujiki et al. · Archives of Toxicology · 2004 · 27 citations

Medicine, Biochemistry, Pharmacology +8

Regulation of insulin-like growth factor binding protein-1 and lipoprotein lipase by the aryl hydrocarbon receptor

Keiichi Minami, Miki Nakajima, Yuto Fujiki et al. · The Journal of Toxicological Sciences · 2008 · 25 citations · Full text

Life Sciences, Biochemistry, Molecular Genetics +12